WHO advises against Gilead’s remdesivir for all hospitalised COVID-19 patients
LONDON (Reuters) – Gilead’s drug remdesivir is not recommended for patients hospitalised with COVID-19, regardless of how ill they are, as there is no evidence it improves survival or reduces the need for ventilation, a World Health Organization panel said on Friday. “The … panel found a lack of evidence that remdesivir improved outcomes that […]
WHO advises against Gilead’s remdesivir for all hospitalised COVID-19 patients Read Post »